Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Americas

      Heptares founder richard henderson receives nobel prize in chemistry 2017 for pioneering work in cryo-em for visualising biological structures

      Americas
      Heptares Therapeutics (“Heptares”), a wholly owned subsidiary of Sosei Group Corporation (“Sosei”; TSE Mothers Index: 4565), is delighted that one of its founders, Richard...

      Aushon BioSystems and ABL, Inc. Announce Adoption of the Cira™ Platform for Multiplex and Ultrasensitive Biomarker Testing

      Americas
      BILLERICA, MASS and Rickville, MD Aushon BioSystems (Aushon) and ABL, Inc. (ABL) today announced that ABL has adopted the Cira platform for multiplex and...

      AI-Driven Discovery of Novel Predictors of Parkinson’s Disease Progression by GNS Healthcare Appears in The Lancet Neurology

      Americas
      GNS Healthcare (GNS), a leading precision medicine company, announced today the discovery of genetic and molecular markers of faster motor progression of Parkinson’s Disease...

      Irvine Scientific Increases Production Capacity of Dry Powder Media for Cell Culture

      Americas
      Irvine Scientific, a world leader in cell culture media development and manufacturing today announced the expansion of its manufacturing facility in Santa Ana, California...

      GE sets new standard for monoclonal antibody purification: Up to 40% increase in capacity

      Americas
      GE Healthcare introduces a new Protein A chromatography resin, MabSelect PrismA, which will help biopharmaceutical manufacturers improve their monoclonal antibody (mAb) purification capacity by...

      BrainStorm Expands Its Patent Portfolio to Include a New US Patent For Its NurOwn Technology for Parkinson’s Disease And ALS

      Americas
      BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, announced that it has...

      Avella selected by AstraZeneca to distribute CALQUENCE

      Americas
      Avella announced that it has been selected by AstraZeneca to distribute CALQUENCE® , a Bruton tyrosine kinase (BTK) inhibitor indicated for patients with MCL...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

      System

      Resources

      Subscribe

      © 2025 Copyright © Valuemediaservices 2025 All rights reserved.